Lunardi-Iskandar; Yanto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lunardi-Iskandar; Yanto.The latest application filed is for "treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin".

Company Profile

Lunardi-Iskandar; Yanto - Gaithersburg MD US
Lunardi-Iskandar; Yanto - Gathersburg MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) Grant 9,175,077 - Gallo , et al. November 3, 2	2015-11-03
Nucleic Acids Encoding Biologically Active Polypeptides Derived From A Novel Early Stage Pregnancy Factor Designated Maternin (ma) App 20140148582 - Gallo; Robert C. ; et al.	2014-05-29
Biologically Active Polypeptides Derived From A Novel Early Stage Pregnancy Factor Designated Maternin (ma) App 20120083587 - Gallo; Robert C. ; et al.	2012-04-05
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin Grant 6,699,656 - Gallo , et al. March 2, 2	2004-03-02
Method for treating HIV Grant 6,620,416 - Gallo , et al. September 16, 2	2003-09-16
Method for promoting hematopoiesis Grant 6,596,688 - Gallo , et al. July 22, 2	2003-07-22
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin App 20030049273 - Gallo, Robert C. ; et al.	2003-03-13
Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin Grant 5,997,871 - Gallo , et al. December 7, 1	1999-12-07
Treatment of cancer with human chorionic gonadotropin Grant 5,877,148 - Lunardi-Iskandar , et al. March 2, 1	1999-03-02
Treatment of cancer with human chorionic gonadotropin Grant 5,677,275 - Lunardi-Iskandar , et al. October 14, 1	1997-10-14